Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15... Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. Show more
October 2, 2024 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: Alzheimer’s disease (“AD”) has become a focal point in the pharmaceutical industry as...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.42 | 3.36382413691 | 101.67 | 105.74 | 99.42 | 7275592 | 102.27316486 | CS |
4 | -8.81 | -7.73485513608 | 113.9 | 114.19 | 99.42 | 6684374 | 107.63141499 | CS |
12 | -33.13 | -23.9690348719 | 138.22 | 139.735 | 99.42 | 4777238 | 115.72833259 | CS |
26 | -28.48 | -21.3221531781 | 133.57 | 148.15 | 99.42 | 4301876 | 125.37831008 | CS |
52 | 2.03 | 1.96972637299 | 103.06 | 148.15 | 94.7313 | 4387283 | 122.02053337 | CS |
156 | 48.655 | 86.2142287587 | 56.435 | 148.15 | 45.755 | 2665907 | 99.9053021 | CS |
260 | 77.6 | 282.284467079 | 27.49 | 148.15 | 24.62 | 2087916 | 84.64179143 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales